The company reported a net profit of Rs 24.61 crores for the Quarter ended 31st Dec 2010 registering a growth of 83 percent against the figure of Rs 13.45 crores for the Quarter ended 31st Dec 2009.
The turnover of the Company also rose by 42.9 percent.
Vice Chairman and the Managing director of the company stated, "Company's focus on high end export markets and on block buster molecule is yielding results as company is giving sustained revenues."
"Going forward company is looking at Quantum leap jump in its efforts to tap regulated markets which will improve the quality of our business and deliver strong numbers on a consistent basis," he added.
Ind-Swift Laboratories limited (ISLL) is a leading global player in Active Pharmaceutical Ingredients and Advanced intermediates.